These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4081792)

  • 1. Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis.
    Benson MD; Aldo-Benson M; Brandt KD
    Semin Arthritis Rheum; 1985 Nov; 15(2 Suppl 1):65-7. PubMed ID: 4081792
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Voltaren on arachidonic acid metabolism in arthritis patients.
    Liauw HL; Ku E; Brandt KD; Benson MD; Aldo-Benson MA; Waiter SL; Lee W; Chan K; Vyas K
    Agents Actions Suppl; 1985; 17():195-9. PubMed ID: 3937448
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased levels of lactoferrin in synovial fluid but not in serum from patients with rheumatoid arthritis.
    Caccavo D; Sebastiani GD; Di Monaco C; Guido F; Galeazzi M; Ferri GM; Bonomo L; Afeltra A
    Int J Clin Lab Res; 1999; 29(1):30-5. PubMed ID: 10356661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and synovial fluid concentrations of diclofenac sodium and its hydroxylated metabolites during once-daily administration of a 100 mg slow-release formulation.
    Fowler PD; Dawes PT; John VA; Shotton PA
    Eur J Clin Pharmacol; 1986; 31(4):469-72. PubMed ID: 3469101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamics of intragastric acidity in patients with osteoarthritis and rheumatoid arthritis during therapy with diclofenac sodium].
    Abdulganieva DI; Belianskaia NE
    Eksp Klin Gastroenterol; 2011; (5):31-4. PubMed ID: 21916232
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis.
    Fowler PD; Shadforth MF; Crook PR; John VA
    Eur J Clin Pharmacol; 1983; 25(3):389-94. PubMed ID: 6628528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein traffic in human synovial effusions.
    Wallis WJ; Simkin PA; Nelp WB
    Arthritis Rheum; 1987 Jan; 30(1):57-63. PubMed ID: 3814198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluids.
    Ahmadzadeh N; Shingu M; Nobunaga M; Tawara T
    Inflammation; 1991 Dec; 15(6):497-503. PubMed ID: 1661709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial fluid and plasma fibronectin levels in rheumatoid arthritis.
    Scott DL; Farr M; Crockson AP; Walton KW
    Clin Sci (Lond); 1982 Jan; 62(1):71-6. PubMed ID: 7056032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of thymosin β4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin β4 with other factors that are involved in inflammation and bone erosion in joints.
    Choi HM; Lee YA; Yang HI; Yoo MC; Kim KS
    Int J Rheum Dis; 2011 Oct; 14(4):320-4. PubMed ID: 22004227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synovial fluid lipids in rheumatoid arthritis and osteoarthritis].
    Kita M
    Igaku Kenkyu; 1969 Jun; 39(3):222-36. PubMed ID: 5389945
    [No Abstract]   [Full Text] [Related]  

  • 14. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
    Menkes CJ; Renoux M; Laoussadi S; Mauborgne A; Bruxelle J; Cesselin F
    J Rheumatol; 1993 Apr; 20(4):714-7. PubMed ID: 7684449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synovial fluid copper and related variables in rheumatoid and degenerative arthritis.
    Scudder PR; McMurray W; White AG; Dormandy TL
    Ann Rheum Dis; 1978 Feb; 37(1):71-2. PubMed ID: 629608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diclofenac/misoprostol. A review of the major clinical trials evaluating its clinical efficacy and upper gastrointestinal tolerability in rheumatoid arthritis and osteoarthritis.
    Downie WW
    Drugs; 1993; 45 Suppl 1():1-6; discussion 36-7. PubMed ID: 7685682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low synovial clearance of iodide provides evidence of hypoperfusion in chronic rheumatoid synovitis.
    Wallis WJ; Simkin PA; Nelp WB
    Arthritis Rheum; 1985 Oct; 28(10):1096-1104. PubMed ID: 4052121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan metabolism in the joint diseases.
    Igari T; Obara K; Ono S; Toba Y
    Acta Vitaminol Enzymol; 1975; 29(1-6):194-7. PubMed ID: 1244092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenic acid in synovial fluid and serum of patients with rheumatoid arthritis, spondyloarthropathy, and osteoarthritis.
    Parada-Turska J; Zgrajka W; Majdan M
    J Rheumatol; 2013 Jun; 40(6):903-9. PubMed ID: 23588943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan metabolism in the synovial fluid in rheumatoid arthritis and osteoarthritis.
    Igari T; Tsuchizawa M
    Tohoku J Exp Med; 1969 Sep; 99(1):73-80. PubMed ID: 5349889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.